Chemomab Therapeutics Ltd. (CMMB)
NASDAQ·Healthcare·Biotechnology
$1.49
-3.25%
Mkt Cap $12.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.20 | -$0.24 | -20.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.20 | -$0.80 | -300.00% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.80 | -$0.36 | +55.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.20 | -$0.14 | +30.00% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.20 | -$0.16 | +20.00% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.20 | -$0.20 | +0.00% | — | — |
| Q3 2024 Aug 21, 2024 | — | — | — | -$0.20 | -$0.26 | -30.00% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.20 | -$0.28 | -40.00% | — | — |
| Q1 2024 Mar 7, 2024 | — | — | — | -$0.40 | -$0.26 | +35.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.60 | -$0.34 | +43.33% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.80 | -$0.72 | +10.00% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.80 | -$0.80 | +0.00% | — | — |
| Q1 2023 Mar 20, 2023 | — | — | — | -$0.80 | -$0.72 | +10.00% | — | — |
| Q4 2022 Nov 11, 2022 | — | — | — | -$0.60 | -$0.70 | -16.67% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.60 | -$0.54 | +10.00% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.40 | -$0.44 | -10.00% | — | — |
| Q1 2022 Mar 9, 2022 | — | — | — | -$0.40 | -$0.44 | -10.00% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.14 | -$0.26 | -79.31% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$0.12 | -$0.26 | -126.09% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.43 | -$0.22 | +48.84% | — | — |